Contraception

Drug-Nutrient Interactions and Nuclear Receptors

12 days ago   |   Indigo Biosciences

INTRODUCTION There are several clinically relevant instances of a food or dietary supplement altering the activity of a pharmaceutical agent. For example, St. John's Wort , a...
Read more ...

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

1 month ago   |   Xconomy

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin...
Read more ...

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

1 month ago   |   Xconomy

A contraceptive patch developed by Agile Therapeutics was awarded FDA approval late Friday, clearing the way for a new birth control option to reach the market. The Agile...
Read more ...

CEOs of Women's Health Companies Fight to Open Investment Floodgates

CEOs of Women's Health Companies Fight to Open Investment Floodgates

2 monthes ago   |   Xconomy

Talking about sex with potential investors? For EvoFem Biosciences CEO Saundra Pelletier, it's the first item on the docket. Her company recently submitted Amphora, a...
Read more ...

Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive

Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive

2 monthes ago   |   Xconomy

Daré Bioscience launched in 2015 with the aim of assembling a portfolio of novel women's health products intended to pique interest from major pharmaceutical companies. Now the...
Read more ...

PACT Pharma bags $75M for neoantigen TCR work, manufacturing; Bayer grabs experimental contraceptive from Daré

2 monthes ago   |   San Diego Biotechnology

? With a new president and chief technical officer in place, next-gen T cell therapy player PACT Pharma has $75 million in fresh financing to expand the scope of its nascent...
Read more ...

 Bayer and Daré Bioscience Announce Exclusive Licensing Agreement for U.S. Commercial Rights to Ovaprene ®, an Investigational Hormone-Free, Monthly Contraceptive

2 monthes ago   |   San Diego Biotechnology

WHIPPANY, N.J. & SAN DIEGO--Bayer, a leader in women's health, and Daré Bioscience, Inc. , a clinical-stage biopharmaceutical company committed to the advancement of innovative...
Read more ...

Daré to Add Microchip-Based Birth Control to Women's Health Portfolio

Daré to Add Microchip-Based Birth Control to Women's Health Portfolio

4 monthes ago   |   Xconomy

The list of activities our smartphones can control grows daily. Transfer money? It's simple. Order groceries? That, too. Turn off the bedroom lights? Check. How about...
Read more ...

Contraception, HIV Services, and PrEP in South African Hair Salons: A Qualitative Study of Owner, Stylist, and Client Perspectives

5 monthes ago   |   Springer   |   2 articles

Abstract Women experience challenges engaging with the healthcare system, but frequently utilize hair salons; these are promising venues for family planning and HIV prevention...
Read more ...

Evofem gets $80 million for vaginal gel contraceptive

9 monthes ago   |   San Diego Biotechnology

San Diego company expects to start selling product next year, assuming approval...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

The financial markets may remain volatile but Keros Therapeutics managed to raise more money in its public market debut than it had initially planned. Late Tuesday the... Read more ...

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Sciences has signed an agreement with South San Francisco biotech Second Genome to use its microbiome drug development expertise to advance the compounds it is... Read more ...

Organovo Future Unclear After Shareholders Reject Tarveda Merger

Organovo Future Unclear After Shareholders Reject Tarveda Merger

A planned merger between struggling 3-D “bioprinter” Organovo and Tarveda Therapeutics, a privately held cancer drug developer looking to join the public markets through a... Read more ...

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

Image by Miroslava Chrienova from Pixabay Our team is proud to announce that PacBio has been working closely with customers to help in the fight against the COVID-19 pandemic... Read more ...

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Some diseases have proven difficult to address using conventional tools of drug discovery that target disease-causing proteins. Roche is placing a $190 million bet on Arrakis... Read more ...

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA's OK to start testing its candidate in healthy volunteers. The... Read more ...

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Therapeutics is cutting workers who sell its only commercialized drug in a corporate reorganization that it says allows it to focus on clinical-stage compounds, including... Read more ...

Creating Consistent Value in Biotech Without Diluting Stakeholders

Creating Consistent Value in Biotech Without Diluting Stakeholders

One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide... Read more ...

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

In the Boston biotech hub, much progress has been made advancing digital health, but significant scientific, technological, financial, and regulatory challenges remain. Join us... Read more ...

Community Health Watch Study to Enhance the COVID-19 Pandemic Response

We're facing times that many of us could never have imagined due to COVID-19. We want to improve how health care systems respond to pandemics. Through the “Pandemic Response... Read more ...